LyondellBasell Industries reported mixed financial results for Q3 2024, with a net income drop but significant progress in sustainability, including new recycling initiatives and strong cash flow.
Amgen’s Q3 2024 results showcase impressive financial performance with $8.5 billion in revenue, reflecting strong growth and strategic expansion in key therapeutic areas.
